Description
DE-OBLIGATING EXCESS FUND IN THE AMOUNT OF $5,849.04.
Base award description: REAGENTS AND SUPPLIES
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-02-14+$700,953= $700,953
- Mod P000012024-09-20+$0= $700,953
- Mod P000022026-04-08-$5,849= $695,104
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-02-14 | +$700,953 | $700,953 | REAGENTS AND SUPPLIES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-09-20 | +$0 | $700,953 | REAGENTS AND SUPPLIES |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2026-04-08 | −$5,849 | $695,104 | DE-OBLIGATING EXCESS FUND IN THE AMOUNT OF $5,849.04. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FGK2QR959BV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0641 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $172,138 | FY2026 |
| 36C24426A0041 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36C24426N0964 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $45,218 | FY2026 |
| 36C24426N0963 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $244,586 | FY2026 |
| 36C26026N0382 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q301 · REFERENCE LABORATORY TESTING | $125,000 | FY2026 |
| 36C24426N0738 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $78,181 | FY2026 |
Other recipients under 6550 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0941 | POLYMEDCO LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $25,596 | FY2026 |
| 36C26226P1513 | GOVERNMENT SCIENTIFIC SOURCE INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $28,264 | FY2026 |
| 36C26226N0903 | BIOMERIEUX INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $67,946 | FY2026 |
| 36C26226N0869 | BECKMAN COULTER, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $111,853 | FY2026 |
| 36C26226N0897 | BIOMERIEUX INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $98,331 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26224P0773_3600_-NONE-_-NONE- · retrieved 2026-09-26.